Fifty
percent of all people with epilepsy are free of seizures so long as they and
their doctors have found the best antiseizure drug regimen for them. The
remaining patients are refractory: that is, they continue to have seizures even
with medical treatment. Sadly, almost half of this group cannot lead fulfilling
lives because their epilepsy interferes with ordinary daily activities. Furthermore,
they are at risk for greater cognitive decline and death.
Fewer
than 5% of epilepsy patients who have scars or other abnormalities identified
on MRI brain scans as epilepsy-inducing and in whom two antiseizure drugs fail
to control their seizures ever gain total seizure control. Epilepsy surgery is
an important treatment option for those with poorly controlled epilepsy who are
“fortunate” to have A) an identifiable brain area causing their seizures, and
B) this abnormality is in a so-called “silent” or, as neurologists say,
“non-exquisite” area of the brain. I say these people are “fortunate” because
these areas—the very front of the frontal lobe and of the temporal
lobe―can be surgically removed without causing any significant deficits
showing up in thinking, intelligence, or in speech, memory, movement, or
sensation.
1. Engel J Jr, McDemott MP, et
al. Early surgical therapy for drug-resistant
temporal lobe epilepsy: a randomized trial. JAMA 2012; 307: 922-930.
2. Berg AT, Mathern GW, et al. Frequency, prognosis and surgical treatment
of structural abnormalities seen with magnetic resonance imaging in childhood
epilepsy. Brain 2009; 132: 2785–2797.
3. Roberts J I, Hrazdil C, et al. Neurologists’ knowledge of and attitudes
toward epilepsy surgery. Neurology 2015; 84: 159-165.
Lance Fogan,
M.D. is Clinical Professor of Neurology at the David Geffen School of Medicine at UCLA. “DINGS” is his first novel. It is a
mother’s dramatic story that teaches
epilepsy.